Does deep brain stimulation improve Parkinson’s disease-related lower urinary tract symptoms and voiding dysfunction?

Main Article Content

Alexandra L. Tabakin
Hari S.G.R. Tunuguntla

Keywords

deep brain stimulation, lower urinary tract symptoms, neuromodulation, Parkinson’s disease, voiding dysfunction

Abstract

Parkinson’s disease (PD), caused by degeneration of dopaminergic neurons, leads to motor and autonomic symptoms. A large proportion of PD patients experience lower urinary tract symptoms (LUTS) and voiding dysfunction, associated with poor quality of life. Deep brain stimulation (DBS) is an adjunctive therapy used in combination with medication for Parkinsonian motor symptoms and is currently being explored to treat PD-related LUTS. This review discusses the current literature on the effects of DBS on lower urinary tract function and whether this modality can be used to modulate PD-related LUTS and voiding dysfunction.

Metrics

Metrics Loading ...
Abstract 37 | HTML Downloads 13 PDF Downloads 15

References

1. Chen SC, Chu PY, Hsieh TH, Li YT, Peng CW. Feasibility of deep brain stimulation for controlling the lower urinary tract functions: An animal study. Clin Neurophysiol. 2017;128(12):2438-49. Epub 2017/11/03. doi: 10.1016/j.clinph.2017.09.102. PubMed PMID: 29096218.

2. Finazzi-Agro E, Peppe A, D'Amico A, Petta F, Mazzone P, Stanzione P, et al. Effects of subthalamic nucleus stimulation on urodynamic findings in patients with Parkinson's disease. J Urol. 2003;169(4):1388-91. Epub 2003/03/12. doi: 10.1097/01.ju.0000055520.88377.dc. PubMed PMID: 12629368.

3. Sakakibara R, Nakazawa K, Uchiyama T, Yoshiyama M, Yamanishi T, Hattori T. Effects of subthalamic nucleus stimulation on the micturation reflex in cats. Neuroscience. 2003;120(3):871-5. Epub 2003/08/05. doi: 10.1016/s0306-4522(03)00319-1. PubMed PMID: 12895527.

4. Picillo M, Palladino R, Barone P, Erro R, Colosimo C, Marconi R, et al. The PRIAMO study: urinary dysfunction as a marker of disease progression in early Parkinson's disease. Eur J Neurol. 2017;24(6):788-95. Epub 2017/04/21. doi: 10.1111/ene.13290. PubMed PMID: 28425642.

5. Stone E, Coote JH, Lovick TA. Effect of electrical vs. chemical deep brain stimulation at midbrain sites on micturition in anaesthetized rats. Acta Physiol (Oxf). 2015;214(1):135-45. Epub 2015/03/18. doi: 10.1111/apha.12491. PubMed PMID: 25778550.

6. Winge K, Nielsen KK. Bladder dysfunction in advanced Parkinson's disease. Neurourol Urodyn. 2012;31(8):1279-83. Epub 2012/04/11. doi: 10.1002/nau.22237. PubMed PMID: 22488851.

7. Roy HA, Pond D, Roy C, Forrow B, Foltynie T, Zrinzo L, et al. Effects of pedunculopontine nucleus stimulation on human bladder function. Neurourol Urodyn. 2018;37(2):726-34. Epub 2017/06/13. doi: 10.1002/nau.23321. PubMed PMID: 28605052.

8. Dafsari HS, Martinez-Martin P, Rizos A, Trost M, Dos Santos Ghilardi MG, Reddy P, et al. EuroInf 2: Subthalamic stimulation, apomorphine, and levodopa infusion in Parkinson's disease. Mov Disord. 2019;34(3):353-65. Epub 2019/02/06. doi: 10.1002/mds.27626. PubMed PMID: 30719763.

9. Dafsari HS, Reddy P, Herchenbach C, Wawro S, Petry-Schmelzer JN, Visser-Vandewalle V, et al. Beneficial Effects of Bilateral Subthalamic Stimulation on Non-Motor Symptoms in Parkinson's Disease. Brain Stimul. 2016;9(1):78-85. Epub 2015/09/20. doi: 10.1016/j.brs.2015.08.005. PubMed PMID: 26385442.

10. Green AL, Stone E, Sitsapesan H, Turney BW, Coote JH, Aziz TZ, et al. Switching off micturition using deep brain stimulation at midbrain sites. Ann Neurol. 2012;72(1):144-7. Epub 2012/07/26. doi: 10.1002/ana.23571. PubMed PMID: 22829274.

11. Herzog J, Weiss PH, Assmus A, Wefer B, Seif C, Braun PM, et al. Subthalamic stimulation modulates cortical control of urinary bladder in Parkinson's disease. Brain. 2006;129(Pt 12):3366-75. Epub 2006/11/02. doi: 10.1093/brain/awl302. PubMed PMID: 17077105.

12. Kessler TM, Burkhard FC, Z'Brun S, Stibal A, Studer UE, Hess CW, et al. Effect of thalamic deep brain stimulation on lower urinary tract function. Eur Urol. 2008;53(3):607-12. Epub 2007/08/10. doi: 10.1016/j.eururo.2007.07.015. PubMed PMID: 17686571.

13. Mock S, Osborn DJ, Brown ET, Stuart Reynolds W, Turchan M, Pallavaram S, et al. The Impact of Pallidal and Subthalamic Deep Brain Stimulation on Urologic Function in Parkinson's Disease. Neuromodulation. 2016;19(7):717-23. Epub 2016/05/14. doi: 10.1111/ner.12446. PubMed PMID: 27172446; PubMed Central PMCID: PMCPMC5052109.

14. Mordasini L, Kessler TM, Kiss B, Schupbach M, Pollo C, Kaelin-Lang A. Bladder function in patients with dystonia undergoing deep brain stimulation. Parkinsonism Relat Disord. 2014;20(9):1015-7. Epub 2014/07/06. doi: 10.1016/j.parkreldis.2014.05.016. PubMed PMID: 24984838.

15. Seif C, Herzog J, van der Horst C, Schrader B, Volkmann J, Deuschl G, et al. Effect of subthalamic deep brain stimulation on the function of the urinary bladder. Ann Neurol. 2004;55(1):118-20. Epub 2004/01/06. doi: 10.1002/ana.10806. PubMed PMID: 14705120.

16. Stefani A, Lozano AM, Peppe A, Stanzione P, Galati S, Tropepi D, et al. Bilateral deep brain stimulation of the pedunculopontine and subthalamic nuclei in severe Parkinson's disease. Brain. 2007;130(Pt 6):1596-607. Epub 2007/01/26. doi: 10.1093/brain/awl346. PubMed PMID: 17251240.

17. Weaver FM, Follett K, Stern M, Hur K, Harris C, Marks WJ, Jr., et al. Bilateral deep brain stimulation vs best medical therapy for patients with advanced Parkinson disease: a randomized controlled trial. JAMA. 2009;301(1):63-73. Epub 2009/01/08. doi: 10.1001/jama.2008.929. PubMed PMID: 19126811; PubMed Central PMCID: PMCPMC2814800.

18. Williams A, Gill S, Varma T, Jenkinson C, Quinn N, Mitchell R, et al. Deep brain stimulation plus best medical therapy versus best medical therapy alone for advanced Parkinson's disease (PD SURG trial): a randomised, open-label trial. Lancet Neurol. 2010;9(6):581-91. Epub 2010/05/04. doi: 10.1016/S1474-4422(10)70093-4. PubMed PMID: 20434403; PubMed Central PMCID: PMCPMC2874872.

19. Witte LP, Odekerken VJJ, Boel JA, Schuurman PR, Gerbrandy-Schreuders LC, de Bie RMA, et al. Does deep brain stimulation improve lower urinary tract symptoms in Parkinson's disease? Neurourol Urodyn. 2018;37(1):354-9. Epub 2017/05/04. doi: 10.1002/nau.23301. PubMed PMID: 28464331.

20. Yamamoto T, Uchiyama T, Asahina M, Yamanaka Y, Hirano S, Higuchi Y, et al. Urinary symptoms are correlated with quality of life after deep brain stimulation in Parkinson's disease. Brain Behav. 2018;8(12):e01164. Epub 2018/11/20. doi: 10.1002/brb3.1164. PubMed PMID: 30451394; PubMed Central PMCID: PMCPMC6305927.

21. Zong H, Meng F, Zhang Y, Wei G, Zhao H. Clinical study of the effects of deep brain stimulation on urinary dysfunctions in patients with Parkinson's disease. Clin Interv Aging. 2019;14:1159-66. Epub 2019/08/17. doi: 10.2147/CIA.S204368. PubMed PMID: 31417246; PubMed Central PMCID: PMCPMC6599892.

22. Sakakibara R, Panicker J, Finazzi-Agro E, Iacovelli V, Bruschini H, Parkinson's Disease Subcomittee TNPCiTICS. A guideline for the management of bladder dysfunction in Parkinson's disease and other gait disorders. Neurourol Urodyn. 2016;35(5):551-63. Epub 2015/03/27. doi: 10.1002/nau.22764. PubMed PMID: 25810035.

23. Tai C, Wang J, Jin T, Wang P, Kim SG, Roppolo JR, et al. Brain switch for reflex micturition control detected by FMRI in rats. J Neurophysiol. 2009;102(5):2719-30. Epub 2009/09/11. doi: 10.1152/jn.00700.2009. PubMed PMID: 19741099; PubMed Central PMCID: PMCPMC2777821.

24. Magerkurth C, Schnitzer R, Braune S. Symptoms of autonomic failure in Parkinson's disease: prevalence and impact on daily life. Clin Auton Res. 2005;15(2):76-82. Epub 2005/04/19. doi: 10.1007/s10286-005-0253-z. PubMed PMID: 15834763.

25. Stohrer M, Blok B, Castro-Diaz D, Chartier-Kastler E, Del Popolo G, Kramer G, et al. EAU guidelines on neurogenic lower urinary tract dysfunction. Eur Urol. 2009;56(1):81-8. Epub 2009/05/01. doi: 10.1016/j.eururo.2009.04.028. PubMed PMID: 19403235.

26. Vurture G, Peyronnet B, Palma JA, Sussman RD, Malacarne DR, Feigin A, et al. Urodynamic Mechanisms Underlying Overactive Bladder Symptoms in Patients With Parkinson Disease. Int Neurourol J. 2019;23(3):211-8. Epub 2019/10/15. doi: 10.5213/inj.1938086.043. PubMed PMID: 31607100; PubMed Central PMCID: PMCPMC6790817.

27. Sakakibara R, Hattori T, Uchiyama T, Yamanishi T. Videourodynamic and sphincter motor unit potential analyses in Parkinson's disease and multiple system atrophy. J Neurol Neurosurg Psychiatry. 2001;71(5):600-6. Epub 2001/10/19. doi: 10.1136/jnnp.71.5.600. PubMed PMID: 11606669; PubMed Central PMCID: PMCPMC1737611.

28. Deep-Brain Stimulation for Parkinson's Disease Study G, Obeso JA, Olanow CW, Rodriguez-Oroz MC, Krack P, Kumar R, et al. Deep-brain stimulation of the subthalamic nucleus or the pars interna of the globus pallidus in Parkinson's disease. N Engl J Med. 2001;345(13):956-63. Epub 2001/09/29. doi: 10.1056/NEJMoa000827. PubMed PMID: 11575287.

29. Herrington TM, Cheng JJ, Eskandar EN. Mechanisms of deep brain stimulation. J Neurophysiol. 2016;115(1):19-38. Epub 2015/10/30. doi: 10.1152/jn.00281.2015. PubMed PMID: 26510756; PubMed Central PMCID: PMCPMC4760496.

30. Johnson MD, Miocinovic S, McIntyre CC, Vitek JL. Mechanisms and targets of deep brain stimulation in movement disorders. Neurotherapeutics. 2008;5(2):294-308. Epub 2008/04/09. doi: 10.1016/j.nurt.2008.01.010. PubMed PMID: 18394571; PubMed Central PMCID: PMCPMC2517242.

31. Astrom M, Diczfalusy E, Martens H, Wardell K. Relationship between neural activation and electric field distribution during deep brain stimulation. IEEE Trans Biomed Eng. 2015;62(2):664-72. Epub 2014/10/29. doi: 10.1109/TBME.2014.2363494. PubMed PMID: 25350910.

32. Okun MS, Gallo BV, Mandybur G, Jagid J, Foote KD, Revilla FJ, et al. Subthalamic deep brain stimulation with a constant-current device in Parkinson's disease: an open-label randomised controlled trial. Lancet Neurol. 2012;11(2):140-9. Epub 2012/01/14. doi: 10.1016/S1474-4422(11)70308-8. PubMed PMID: 22239915.

33. Bratsos S, Karponis D, Saleh SN. Efficacy and Safety of Deep Brain Stimulation in the Treatment of Parkinson's Disease: A Systematic Review and Meta-analysis of Randomized Controlled Trials. Cureus. 2018;10(10):e3474. Epub 2019/01/17. doi: 10.7759/cureus.3474. PubMed PMID: 30648026; PubMed Central PMCID: PMCPMC6318091.

34. Charles D, Konrad PE, Neimat JS, Molinari AL, Tramontana MG, Finder SG, et al. Subthalamic nucleus deep brain stimulation in early stage Parkinson's disease. Parkinsonism Relat Disord. 2014;20(7):731-7. Epub 2014/04/29. doi: 10.1016/j.parkreldis.2014.03.019. PubMed PMID: 24768120; PubMed Central PMCID: PMCPMC4103427.

35. Deuschl G, Schade-Brittinger C, Krack P, Volkmann J, Schafer H, Botzel K, et al. A randomized trial of deep-brain stimulation for Parkinson's disease. N Engl J Med. 2006;355(9):896-908. Epub 2006/09/01. doi: 10.1056/NEJMoa060281. PubMed PMID: 16943402.

36. Premarket Approval (PMA) Silver Spring, MD: U.S. Food & Drug Administration; 2020 [cited 2002]. Available from: https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfpma/pma.cfm?id=P960009S007.

37. Schuepbach WM, Rau J, Knudsen K, Volkmann J, Krack P, Timmermann L, et al. Neurostimulation for Parkinson's disease with early motor complications. N Engl J Med. 2013;368(7):610-22. Epub 2013/02/15. doi: 10.1056/NEJMoa1205158. PubMed PMID: 23406026.

38. Vishwajit S, Herco M, Siddiqui MS, Cartwright M, Patel BN, Badlani GH. THE EFFECT OF DEEP BRAIN STIMULATION ON VOIDING DYSFUNCTION IN PARKINSON'S DISEASE AND ESSENTIAL TREMOR. J Urol. 2009;18:673-4. doi: https://doi.org/10.1016/S0022-5347(09)61888-7.

39. Winge K, Nielsen KK, Stimpel H, Lokkegaard A, Jensen SR, Werdelin L. Lower urinary tract symptoms and bladder control in advanced Parkinson's disease: effects of deep brain stimulation in the subthalamic nucleus. Mov Disord. 2007;22(2):220-5. Epub 2006/11/30. doi: 10.1002/mds.21253. PubMed PMID: 17133504.

40. Buhmann C, Huckhagel T, Engel K, Gulberti A, Hidding U, Poetter-Nerger M, et al. Adverse events in deep brain stimulation: A retrospective long-term analysis of neurological, psychiatric and other occurrences. PLoS One. 2017;12(7):e0178984. Epub 2017/07/06. doi: 10.1371/journal.pone.0178984. PubMed PMID: 28678830; PubMed Central PMCID: PMCPMC5497949.

41. Constantinescu R, Eriksson B, Jansson Y, Johnels B, Holmberg B, Gudmundsdottir T, et al. Key clinical milestones 15 years and onwards after DBS-STN surgery-A retrospective analysis of patients that underwent surgery between 1993 and 2001. Clin Neurol Neurosurg. 2017;154:43-8. Epub 2017/01/24. doi: 10.1016/j.clineuro.2017.01.010. PubMed PMID: 28113102.

42. Krack P, Batir A, Van Blercom N, Chabardes S, Fraix V, Ardouin C, et al. Five-year follow-up of bilateral stimulation of the subthalamic nucleus in advanced Parkinson's disease. N Engl J Med. 2003;349(20):1925-34. Epub 2003/11/14. doi: 10.1056/NEJMoa035275. PubMed PMID: 14614167.

43. Dalmose AL, Bjarkam CR, Sorensen JC, Djurhuus JC, Jorgensen TM. Effects of high frequency deep brain stimulation on urine storage and voiding function in conscious minipigs. Neurourol Urodyn. 2004;23(3):265-72. Epub 2004/04/21. doi: 10.1002/nau.20026. PubMed PMID: 15098225.

44. Herzog J, Weiss PH, Assmus A, Wefer B, Seif C, Braun PM, et al. Improved sensory gating of urinary bladder afferents in Parkinson's disease following subthalamic stimulation. Brain. 2008;131(Pt 1):132-45. Epub 2007/11/06. doi: 10.1093/brain/awm254. PubMed PMID: 17977862.

45. Arya NG, Weissbart SJ, Xu S, Rao H. Brain activation in response to bladder filling in healthy adults: An activation likelihood estimation meta-analysis of neuroimaging studies. Neurourol Urodyn. 2017;36(4):960-5. Epub 2016/07/02. doi: 10.1002/nau.23058. PubMed PMID: 27367364.

46. Harvie C, Weissbart SJ, Kadam-Halani P, Rao H, Arya LA. Brain activation during the voiding phase of micturition in healthy adults: A meta-analysis of neuroimaging studies. Clin Anat. 2019;32(1):13-9. Epub 2018/08/03. doi: 10.1002/ca.23244. PubMed PMID: 30069958; PubMed Central PMCID: PMCPMC6309926.

47. Hariz MI, Krack P, Alesch F, Augustinsson LE, Bosch A, Ekberg R, et al. Multicentre European study of thalamic stimulation for parkinsonian tremor: a 6 year follow-up. J Neurol Neurosurg Psychiatry. 2008;79(6):694-9. Epub 2007/09/28. doi: 10.1136/jnnp.2007.118653. PubMed PMID: 17898034.

48. Solopchuk O, Sebti M, Bouvy C, Benoit CE, Warlop T, Jeanjean A, et al. Locus Coeruleus atrophy doesn't relate to fatigue in Parkinson's disease. Sci Rep. 2018;8(1):12381. Epub 2018/08/19. doi: 10.1038/s41598-018-30128-y. PubMed PMID: 30120287; PubMed Central PMCID: PMCPMC6098016.

49. Jensen KN, Deding D, Sorensen JC, Bjarkam CR. Long-term implantation of deep brain stimulation electrodes in the pontine micturition centre of the Gottingen minipig. Acta Neurochir (Wien). 2009;151(7):785-94; discussion 94. Epub 2009/05/01. doi: 10.1007/s00701-009-0334-1. PubMed PMID: 19404572.

50. Deep Brain Stimulation in Patients with LUTS: NIH US National Library of Medicine; 2018 [cited 2020]. Available from: https://clinicaltrials.gov/ct2/show/NCT03202251?term=deep+brain+stimulation+urinary&draw=2&rank=2.

51. Praveen Rajneesh C, Lai CH, Chen SC, Hsieh TH, Chin HY, Peng CW. Improved voiding function by deep brain stimulation in traumatic brain-injured animals with bladder dysfunctions. Int Urol Nephrol. 2019;51(1):41-52. Epub 2018/11/27. doi: 10.1007/s11255-018-2028-1. PubMed PMID: 30474784.

52. Deep Brain Stimulation in Patients With Incomplete Spinal Cord Injury for Improvement of Gait (DBS-SCI): NIH US National Library of Medicine; 2020 [cited 2020]. Available from: https://clinicaltrials.gov/ct2/show/NCT03053791?term=deep+brain+stimulation+urinary&draw=2&rank=5.